Trials / Unknown
UnknownNCT02340741
Insufflation of Carbon Dioxide During Cardiac Surgery as Prevention Neurologic Complications
Assessing of Carbon Dioxide Insufflation on the Neurological Complications During Open Heart Operations
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 334 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Effect of intraoperative insufflation of carbon dioxide on the neurologic complications in the early postoperative period after open cardiac surgery.
Detailed description
Arterial air embolism in cardiac surgery is not a rare complication, leading to neurological damage in the early postoperative period of 3-5%. Insufflation of carbon dioxide (CO2) into the operative field to prevent cerebral or myocardial damage by air embolism is reported since 1967 in open heart surgery (Selman MW et al. 1967). Carbon dioxide fills the thoracic cavity by gravity and replaces air if adequately insufflated. Because solubility of CO2 is better than that of air, occlusion or flow disruption in arteries of the brain or the heart is thought to be diminished. Despite carefully performed deairing procedures as puncturing of the ascending aorta and cardiac massage, transcranial Doppler studies revealed large amounts of emboli during the first ejections of the beating heart (van der Linden J et al. 1991). In patiens with minimally invasive approach and redo valve surgery, deairing of the cardiac chambers has become more difficult. Although the use of carbon dioxide when filling in the surgical field, as the prevention of air embolism reduces the number of intracardiac emboli according to transesophageal echocardiography there is no evidence of a sustained reduction in cerebrovascular events (G. Salvatore al. 2009).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | conventional prophylaxis of aeroembolism | 167 patients will be enrolled. Will perform standard way of aeroembolism prevention |
| PROCEDURE | conventional prophylaxis plus CO2 insufflation | 167 patients will be enrolled. Will perform standard way of aeroembolism prevention and insufflation of carbon dioxide |
| PROCEDURE | cardiac surgery with opening of heart chambers | Patients with different clinical diagnoses, which is planned to cardiac surgery with the opening heart cavities |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2015-01-19
- Last updated
- 2016-03-22
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02340741. Inclusion in this directory is not an endorsement.